These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 12403032

  • 1. A blind parallel comparative study of the efficacy and safety of rovamycin versus augmentin in the treatment of acute otitis media.
    Mgbor NC, Umeh RE.
    West Afr J Med; 2002; 21(2):117-20. PubMed ID: 12403032
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M, Sinha R, Murali MV, Trihan P, Singhal PK.
    Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
    [Abstract] [Full Text] [Related]

  • 3. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW, Latiolais T, Lewis B, Pistorius B, Bottenfield G, Moore WH, Garrett A, Stewart TD, Aoki J, Spiegel C, Boettger D, Shemer A.
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group.
    Damrikarnlert L, Jauregui AC, Kzadri M.
    J Chemother; 2000 Feb; 12(1):79-87. PubMed ID: 10768519
    [Abstract] [Full Text] [Related]

  • 5. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
    Noel GJ, Blumer JL, Pichichero ME, Hedrick JA, Schwartz RH, Balis DA, Melkote R, Bagchi P, Arguedas A.
    Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
    [Abstract] [Full Text] [Related]

  • 6. Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Arguedas A, Soley C, Kamicker BJ, Jorgensen DM.
    Int J Infect Dis; 2011 Apr; 15(4):e240-8. PubMed ID: 21269858
    [Abstract] [Full Text] [Related]

  • 7. Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.
    Casellas JM, Israele V, Marín M, Ishida MT, Heguilen R, Soutric J, Arenoso H, Sibbald A, Stamboulian D.
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1225-33. PubMed ID: 16061111
    [Abstract] [Full Text] [Related]

  • 8. A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
    Subba Rao SD, Macias MP, Dillman CA, Ramos BD, Kierszenbaum JS, Soliman AE.
    J Chemother; 1998 Dec; 10(6):460-8. PubMed ID: 9876054
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
    Poachanukoon O, Kitcharoensakkul M.
    Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
    [Abstract] [Full Text] [Related]

  • 10. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
    Block SL, Schmier JK, Notario GF, Akinlade BK, Busman TA, Mackinnon GE, Halpern MT, Nilius AM.
    Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
    [Abstract] [Full Text] [Related]

  • 11. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B, Celtik C, Oner N, Küçükuğurluoğlu Y, Güzel A, Yildirim C, Adali MK.
    Turk J Pediatr; 2007 Sep; 49(4):390-6. PubMed ID: 18246740
    [Abstract] [Full Text] [Related]

  • 12. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
    Bucher HC, Tschudi P, Young J, Périat P, Welge-Lüussen A, Züst H, Schindler C, BASINUS (Basel Sinusitis Study) Invetigators.
    Arch Intern Med; 2007 Sep; 163(15):1793-8. PubMed ID: 12912714
    [Abstract] [Full Text] [Related]

  • 13. [Use of rovamycin and amox-clav in patients with infectious-inflammatory pathology of the ORL organs].
    Kriukov AI, Poliakova TS, Ogorodnikov DS, Gaĭvoronskaia GA.
    Vestn Otorinolaringol; 1996 Sep; (2):42-5. PubMed ID: 8711846
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of acute non-chlamydial salpingitis. Study of the efficacy and tolerance of a single-therapy antibiotic: Augmentin].
    Tison E, Marpeau L, Pigné A, Tessier F, Barrat J.
    J Gynecol Obstet Biol Reprod (Paris); 1988 Sep; 17(4):513-9. PubMed ID: 3209830
    [Abstract] [Full Text] [Related]

  • 15. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B.
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [Abstract] [Full Text] [Related]

  • 16. [Rovamycin (spiramycin)--a macrolide antibiotic for intravenous administration: a trial in the treatment of pneumonia].
    Strachunskiĭ LS, Sudilovskaia NN, Melikhov OG.
    Ter Arkh; 1995 Jan; 67(3):7-11. PubMed ID: 7770811
    [Abstract] [Full Text] [Related]

  • 17. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R.
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [Abstract] [Full Text] [Related]

  • 18. [Experience with rovamycin and roxithromycin in patients with chronic bronchitis in the presence of posttuberculous changes].
    Sobeleva LG, Komlev AD, Korovina OV.
    Probl Tuberk; 2002 Dec; (2):27-9. PubMed ID: 11899800
    [Abstract] [Full Text] [Related]

  • 19. Is acute otitis media a treatable disease?
    Klein JO.
    N Engl J Med; 2011 Jan 13; 364(2):168-9. PubMed ID: 21226583
    [No Abstract] [Full Text] [Related]

  • 20. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A, Dagan R, Pichichero M, Leibovitz E, Blumer J, McNeeley DF, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2006 Dec 13; 25(12):1102-9. PubMed ID: 17133154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.